IXC 5.26% 7.2¢ invex therapeutics ltd

Parkinsons

  1. 190 Posts.
    lightbulb Created with Sketch. 22
    Read this in The Times in the UK with excitement, and then alarm. https://www.thetimes.co.uk/edition/news/common-diabetes-drug-may-be-treatment-for-parkinson-s-disease-xhz3cvtzx

    Forgive me if I am loose on the details - but I read here that University College of London are about to launch a phase III trial into Parkinson's Disease using Exenitide.

    I believe Exenitide is the same drug IXC are re-purposing for IIH. Is this correct?

    If so, I thought we had global patent over it's use for several purposes not just IIH?

    I assume IXC is playing no role in this study?
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
-0.004(5.26%)
Mkt cap ! $5.411M
Open High Low Value Volume
7.3¢ 7.3¢ 7.2¢ $2.243K 30.74K

Buyers (Bids)

No. Vol. Price($)
1 38792 7.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 4000 1
View Market Depth
Last trade - 12.37pm 22/07/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.